Skip to content
Use caution Drug recall · FDA · Published April 14, 2014

Upsher-Smith Recalls Oxandrolone Tablets Due to Missing Labels

Upsher-Smith Laboratories recalls 1,185 bottles of Oxandrolone Tablets USP 10 mg because the primary bottle label is missing. Check your medication packaging.

🇺🇸 FDA recall #D-1255-2014DrugUpsher-Smith ›
Take action

Contact the company

Recalling firmUpsher Smith Laboratories, Inc.6701 Evenstad Drive · Maple Grove, MN 55369
✎ GovInfoNow plain-language explainer

Upsher-Smith Laboratories is recalling 1,185 bottles of Oxandrolone Tablets, USP, 10 mg because the primary label on the bottle is missing. The product was manufactured by Pharmaceutics International, Inc., and distributed nationwide. While the shipper boxes were correctly labeled, the individual bottles lacked identification. Read more at govinfonow.com/recall/46136-upsher-smith-laboratories-inc-recalls-oxandrolone-tablets-usp-10-mg.

Source Summary by GovInfoNow · govinfonow.com/recall/46136-upsher-smith-laboratories-inc-recalls-oxandrolone-tablets-usp-10-mg · Updated October 13, 2026 · FDA enforcement record: FDA #D-1255-2014

Cite this page

“Upsher-Smith Recalls Oxandrolone Tablets Due to Missing Labels.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46136-upsher-smith-laboratories-inc-recalls-oxandrolone-tablets-usp-10-mg. Based on FDA recall #D-1255-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1255-2014%22&limit=1).

The FDA announced on April 14, 2014, that Upsher-Smith Laboratories recalled Oxandrolone Tablets USP 10 mg due to missing primary labels. The agency stated the recall was voluntary and involved 1,185 bottles distributed nationwide.

How to tell if you have it

  • Brand: Upsher-Smith
  • Product: Oxandrolone Tablets USP 10 mg
  • NDC: 0245-0272-06
  • Lot #: 2802.042A
  • Expiration: 10/2015
  • Packaging: 60-count bottle

The hazard

According to the FDA, three cases totaling 36 bottles were packaged without primary labels on the bottle. These cases were sealed with tamper-evident tape and erroneously shipped to Upsher-Smith.

Context

GovInfoNow's records show Upsher Smith Laboratories has issued four other recalls since November 20, 2012. Other recent recalls of similar products include American Regent Levocarnitine Injection Recall (April 16, 2026) and Unichem Recalls Doxazosin 4mg Tablets Due to Wrong ID Imprint (January 21, 2026).

How to tell if you have this one

Look for a 60-count bottle of Oxandrolone Tablets, USP, 10 mg manufactured by Upsher-Smith Labs or Pharmaceutics International, Inc. Specifically check if the primary label on the bottle is missing. Affected bottles have NDC 0245-0272-06 and Lot #2802.042A with an expiration date of 10/2015.

  • Brand
    Upsher-Smith
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Medication

    Inspect your bottle of Oxandrolone Tablets to see if the primary label is missing.

  2. Contact Your Pharmacist

    If you have the recalled product, contact your pharmacist or healthcare provider for instructions on how to proceed.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 3 months after the firm started it.

1. Firm started the recall: Apr 14, 201412. FDA classified it Class III: Apr 23, 201423. Published in FDA’s Enforcement Report: Apr 30, 201434. FDA terminated the recall: Jul 1, 201442014
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1255-2014 (April 14, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1255-2014 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA